Secondly, we constructed a lysosomal-related gene signature consisting of CLN3, GBA, CTSA, BSG, APLN, SORT1, ANXA2, and LAPTM4B, which demonstrated high performance in the diagnosis and prognosis of HCC patients. This evidence concerns the gene SORT1 and hepatocellular carcinoma.